# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-023095
Filing Date
2024-04-29
Accepted
2024-04-29 17:06:04
Documents
6
Period of Report
2024-06-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20024289x1_def14a.htm | DEF 14A | 1113451
2 |  | logo_ardelyxsymbol.jpg | GRAPHIC | 20032
3 |  | ny20024289x1_pc01.jpg | GRAPHIC | 635569
4 |  | ny20024289x1_pc02.jpg | GRAPHIC | 407225
5 |  | ny20024289x1_pvp01.jpg | GRAPHIC | 159469
6 |  | ny20024289x1_pvp02.jpg | GRAPHIC | 157523
| Complete submission text file | 0001140361-24-023095.txt |  | 3013637

Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36485 | Film No.: 24892453
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)